Fulcrum Therapeutics, Inc.·4

Jan 27, 4:30 PM ET

Thomson Peter G. 4

4 · Fulcrum Therapeutics, Inc. · Filed Jan 27, 2021

Insider Transaction Report

Form 4
Period: 2021-01-25
Thomson Peter G.
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2021-01-25+40,00040,000 total
    Exercise: $13.09Exp: 2031-01-24Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 25, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2021, subject to continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION